Related Experiment Video
Updated: Jan 8, 2026
09:47
Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
4.3K
Protocol for differentiating patient-derived iPSCs into photoreceptor-like cells
1Division of Molecular and Cellular Biology, National Institute of Sensory Organs, NHO Tokyo Medical Center, Tokyo 152-8902, Japan.
STAR Protocols
|December 20, 2025
Summary
Researchers developed a new protocol using patient blood-derived induced pluripotent stem cells (iPSCs) to model inherited retinal dystrophies (IRDs). This method creates photoreceptor-like cells for studying IRD pathogenesis.
Area of Science:
- Biomedical research
- Stem cell biology
- Ophthalmology
Background:
- Inherited retinal dystrophies (IRDs) are challenging to study directly due to the difficulty of obtaining retinal biopsies.
- Occult macular dystrophy is an autosomal-dominant IRD that requires innovative research models.
Purpose of the Study:
- To present a novel protocol for modeling inherited retinal dystrophies using patient-derived induced pluripotent stem cells (iPSCs).
- To enable mutation-focused investigation of IRD pathogenesis by creating a relevant cellular model.
Main Methods:
- Generation of induced pluripotent stem cells (iPSCs) from patient blood samples.
- Differentiation of iPSCs into photoreceptor-like cells using a tetracycline-inducible PiggyBac vector to transduce CRX and NEUROD1.
- Validation of photoreceptor marker expression to confirm successful differentiation.
Main Results:
- Successful differentiation of iPSCs into photoreceptor-like cells expressing key photoreceptor markers.
- Establishment of a viable in vitro model for studying occult macular dystrophy.
Conclusions:
- The developed protocol provides a feasible method for modeling IRDs, specifically occult macular dystrophy, using patient-derived iPSCs.
- This approach facilitates detailed investigation into the molecular mechanisms underlying IRD pathogenesis.
Related Concept Videos
01:22iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
01:13Induced Pluripotent Stem Cells
27.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.2K
01:21EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K